Search Results

Filter
  • 1-10 of  11,224 results for ""C-reactive protein""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Tocilizumab demonstrates superiority in decreasing C-reactive protein levels in hospitalized COVID-19 patients, compared to standard care treatment alone.

  • Authors : Calderón-Ochoa C; Autonomous University of Chihuahua, Faculty of Medicine and Biomedical Sciences, Laboratory of Pharmacoepidemiology, Chihuahua, Mexico.; Plamenov-Donchev N

Subjects: Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/therapeutic use ; C-Reactive Protein*/C-Reactive Protein*/C-Reactive Protein*/analysis ; C-Reactive Protein*/C-Reactive Protein*/C-Reactive Protein*/metabolism

  • Source: Microbiology spectrum [Microbiol Spectr] 2024 Jun 04; Vol. 12 (6), pp. e0249823. Date of Electronic Publication: 2024 Apr 30.Publisher: ASM Press Country of Publication: United States NLM ID: 101634614 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Interplay of inflammatory markers and anti-SARS-CoV-2 antibodies in COVID-19 mortality: A prospective cohort study.

  • Authors : Mink S; Central Medical Laboratories, Feldkirch, Austria; Private University in the Principality of Liechtenstein, Triesen, Principality of Liechtenstein. Electronic address: .

Subjects: COVID-19*/COVID-19*/COVID-19*/mortality ; COVID-19*/COVID-19*/COVID-19*/immunology ; COVID-19*/COVID-19*/COVID-19*/blood

  • Source: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2024 Jun; Vol. 143, pp. 107016. Date Publisher: Elsevier Country of Publication: Canada NLM ID: 9610933 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3511

Record details

×
Academic Journal

C-reactive protein as an effector molecule in Covid-19 pathogenesis.

  • Authors : Mosquera-Sulbaran JA; Instituto de Investigaciones Clinicas 'Dr. Americo Negrette', Facultad de Medicina, Universidad del Zulia, Maracaibo, Venezuela.; Pedreañez A

Subjects: COVID-19 Drug Treatment*; Anti-Inflammatory Agents/Anti-Inflammatory Agents/Anti-Inflammatory Agents/*therapeutic use ; C-Reactive Protein/C-Reactive Protein/C-Reactive Protein/*antagonists & inhibitors

  • Source: Reviews in medical virology [Rev Med Virol] 2021 Nov; Vol. 31 (6), pp. e2221. Date of Electronic Publication: 2021 Feb 17.Publisher: Wiley Country of Publication: England NLM ID: 9112448 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1099-1654

Record details

×
Academic Journal

Correlation of myeloid-derived suppressor cells with C-reactive protein, ferritin and lactate dehydrogenase levels in patients with severe COVID-19.

  • Authors : Emsen A; Department of Pediatric Immunology and Allergy, Faculty of Medicine, Selcuk University, Konya, Turkey.; Sumer S

Subjects: Acute-Phase Proteins/Acute-Phase Proteins/Acute-Phase Proteins/*metabolism ; C-Reactive Protein/C-Reactive Protein/C-Reactive Protein/*metabolism ; COVID-19/COVID-19/COVID-19/*metabolism

  • Source: Scandinavian journal of immunology [Scand J Immunol] 2022 Jan; Vol. 95 (1), pp. e13108. Date of Electronic Publication: 2021 Oct 15.Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 0323767 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

A meta-analysis of SARS-CoV-2 patients identifies the combinatorial significance of D-dimer, C-reactive protein, lymphocyte, and neutrophil values as a predictor of disease severity.

  • Authors : Singh K; Department of Pathology, Stanford University, Stanford, CA, USA.; Mittal S

Subjects: C-Reactive Protein/C-Reactive Protein/C-Reactive Protein/*metabolism ; COVID-19/COVID-19/COVID-19/*diagnosis ; Fibrin Fibrinogen Degradation Products/Fibrin Fibrinogen Degradation Products/Fibrin Fibrinogen Degradation Products/*metabolism

  • Source: International journal of laboratory hematology [Int J Lab Hematol] 2021 Apr; Vol. 43 (2), pp. 324-328. Date of Electronic Publication: 2020 Oct 03.Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 101300213 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Early Prediction of Disease Progression in Patients with Severe COVID-19 Using C-Reactive Protein to Albumin Ratio.

  • Authors : Li Y; The Department of Respiratory Medicine, Xiangya Hospital, Central South University, Changsha 410008, China.; Li H

Subjects: C-Reactive Protein/C-Reactive Protein/C-Reactive Protein/*metabolism ; COVID-19/COVID-19/COVID-19/*diagnosis ; Coronary Disease/Coronary Disease/Coronary Disease/*diagnosis

  • Source: Disease markers [Dis Markers] 2021 Dec 03; Vol. 2021, pp. 6304189. Date of Electronic Publication: 2021 Dec 03 (Print Publication: 2021).Publisher: Hindawi Pub. Corp Country of Publication: United States NLM ID: 8604127 Publication Model: eCollection Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Relationship between lymphocyte subsets values and C-reactive protein in COVID-19 patients.

Subjects: C-Reactive Protein/C-Reactive Protein/C-Reactive Protein/*analysis ; COVID-19/COVID-19/COVID-19/*immunology ; SARS-CoV-2/SARS-CoV-2/SARS-CoV-2/*immunology

  • Source: Cytometry. Part A : the journal of the International Society for Analytical Cytology [Cytometry A] 2021 May; Vol. 99 (5), pp. 462-465. Date of Electronic Publication: 2021 Mar 02.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 101235694 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

C-Reactive Protein Triggers Cell Death in Ischemic Cells.

  • Authors : Sheriff A; Pentracor GmbH, Hennigsdorf, Germany.; Medizinische Klinik m.S. Gastroenterologie/Infektiologie/Rheumatologie, Charité Universitätsmedizin, Berlin, Germany.

Subjects: C-Reactive Protein/C-Reactive Protein/C-Reactive Protein/*immunology ; COVID-19/COVID-19/COVID-19/*immunology ; Myocardial Infarction/Myocardial Infarction/Myocardial Infarction/*immunology

  • Source: Frontiers in immunology [Front Immunol] 2021 Feb 10; Vol. 12, pp. 630430. Date of Electronic Publication: 2021 Feb 10 (Print Publication: 2021).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

×
Report

Circulating levels of IL-2, IL-4, TNF-α, IFN-γ, and C-reactive protein are not associated with severity of COVID-19 symptoms.

  • Authors : Luo W; Department of Respiratory and Critical Care, First Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang, China.; Zhang JW

Subjects: SARS-CoV-2*; C-Reactive Protein/C-Reactive Protein/C-Reactive Protein/*metabolism ; COVID-19/COVID-19/COVID-19/*blood

  • Source: Journal of medical virology [J Med Virol] 2021 Jan; Vol. 93 (1), pp. 89-91. Date of Electronic Publication: 2020 Jun 19.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 7705876 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Report

Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19.

  • Authors : Gritti G; Hematology Unit, Azienda Socio Sanitario Territoriale Papa Giovanni XXIII, Bergamo, Italy. .; Raimondi F

Subjects: Ventilators, Mechanical*; Antibodies, Monoclonal/Antibodies, Monoclonal/Antibodies, Monoclonal/*therapeutic use ; C-Reactive Protein/C-Reactive Protein/C-Reactive Protein/*metabolism

  • Source: Leukemia [Leukemia] 2021 Sep; Vol. 35 (9), pp. 2710-2714. Date of Electronic Publication: 2021 May 24.Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium:

Record details

×
  • 1-10 of  11,224 results for ""C-reactive protein""